Loading…
Arcadia Biosciences, Inc. is projected to rise to $0.8004 by 2027, a +21% move from its current price of $0.6597. RKDA is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $0.6378 | $0.6607 | $0.6844 | +0.15% |
| Aug 6 | $0.6294 | $0.6617 | $0.6956 | +0.30% |
| Aug 7 | $0.6233 | $0.6627 | $0.7045 | +0.45% |
| Aug 8 | $0.6184 | $0.6637 | $0.7122 | +0.60% |
| Aug 9 | $0.6142 | $0.6647 | $0.7193 | +0.75% |
| Aug 10 | $0.6105 | $0.6656 | $0.7258 | +0.90% |
| Aug 11 | $0.6072 | $0.6666 | $0.7319 | +1.05% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.6072 | $0.6666 | $0.7319 | +1.05% |
| Week 2 | $0.5903 | $0.6737 | $0.7688 | +2.12% |
| Week 3 | $0.579 | $0.6808 | $0.8004 | +3.19% |
| Week 4 | $0.5707 | $0.6879 | $0.8293 | +4.28% |
| Week 5 | $0.5641 | $0.6952 | $0.8567 | +5.38% |
| Week 6 | $0.5588 | $0.7025 | $0.8832 | +6.48% |
| Week 7 | $0.5544 | $0.7099 | $0.909 | +7.61% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Arcadia Biosciences, Inc. trades under the symbol RKDA and belongs to the Consumer Defensive sector. The company develops plant-based food and beverage products for the United States market.
It focuses on crop improvements, primarily in wheat, to enhance farm economics by improving field performance and the value of crops as food ingredients. Its product line includes GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring. Arcadia Biosciences was incorporated in 2002 and is headquartered in Dallas, Texas.
Arcadia Biosciences, Inc. (RKDA) is listed with a current price of $0.661 and a market capitalization of $1.44M, ranking 5502 by size. This places the stock among smaller-cap shares within the Consumer Defensive universe. The current price and market position frame a compact, highly speculative profile.
A major floor 21.6% below — a decisive break under it would weaken the trend.
The nearest floor, 6.0% below — buyers have tended to step in here.
The nearest ceiling, 17.8% above — a clean break opens room to run.
A major ceiling 157.7% above — clearing it would confirm fresh momentum.
Key RKDA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of RKDA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.6354 | Buy | $0.6347 | Buy |
| MA 10 | $0.6427 | Buy | $0.6429 | Buy |
| MA 20 | $0.6579 | Buy | $0.6693 | Sell |
| MA 50 | $0.7872 | Sell | $0.8037 | Sell |
| MA 100 | $1.06 | Sell | $1.13 | Sell |
| MA 200 | $2.01 | Sell | $1.78 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 38.03 | Neutral |
| Stoch RSI (14) | 66.09 | Neutral |
| CCI (20) | -89.52 | Neutral |
| Williams %R (14) | -92.65 | Info |
| MACD (12,26,9) | 0.01 | Buy |
| ROC (12) | -5.45 | Sell |
| Bollinger %B (20,2) | 0.21 | Neutral |
| Stochastic %K (14) | 7.35 | Buy |
| TRIX (15) | -0.99 | Sell |
| Awesome (5,34) | -0.07 | Sell |
| Ultimate (7,14,28) | 41.28 | Neutral |
| Momentum (10) | -0.05 | Sell |
| Aroon Osc (25) | -32.00 | Sell |
| Hull MA (9) | 0.63 | Buy |
| ADX (14) | 24.72 | Sell |
| ATR (14) | 0.02 | Info |
The 30-day technical picture is neutral on near-term momentum. RSI14 sits at 40, indicating modest selling pressure, while the 50-day simple moving average stands at $0.8861 and the 200-day simple moving average at $2.18. These moving averages suggest the stock may hover near recent levels before a clearer directional move.
On the chart, immediate support is reported at $0.62 and resistance at $1.07, with a 30-day price range from $0.4886 to $0.8943. The stock also exhibits high annualized volatility at 90%, underscoring substantial price swings relative to its current price.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.62 | $0.6597 | $0.9756 | 0% | Neutral | |
| $0.6215 | $0.8004 | $1.10 | +21% | Bullish | |
| $0.5894 | $0.7883 | $1.13 | +19% | Neutral | |
| $0.5949 | $0.821 | $1.23 | +24% | Bullish | |
| $0.5319 | $0.7549 | $1.16 | +14% | Neutral | |
| $0.4922 | $0.7166 | $1.13 | +9% | Neutral | |
| $0.5057 | $0.7541 | $1.22 | +14% | Neutral | |
| $0.6028 | $0.9194 | $1.52 | +39% | Bullish | |
| $0.6732 | $1.05 | $1.76 | +59% | Bullish | |
| $0.6305 | $1.00 | $1.72 | +52% | Bullish | |
| $0.6903 | $1.21 | $2.23 | +83% | Bullish | |
| $1.06 | $2.20 | $4.51 | +234% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $0.62 | $0.6597 | $0.8265 | +0.00% |
| September 2026 | $0.6196 | $0.7388 | $0.9098 | +11.98% |
| October 2026 | $0.6285 | $0.7561 | $0.9442 | +2.35% |
| November 2026 | $0.6141 | $0.7443 | $0.9398 | -1.56% |
| December 2026 | $0.627 | $0.765 | $0.9756 | +2.78% |
Click any year to see its month-by-month RKDA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The RKDA price prediction for 2026 points to an average of $0.6597 (low $0.62, high $0.9756) — a potential gain of 0% on today's $0.6597. A consolidation phase looks the most probable path here.
In 2027, RKDA is projected to trade between $0.6215 and $1.10, averaging $0.8004 — a potential gain of +21% from today's $0.6597. That is up +21% on the projected 2026 average. Momentum favours further upside here.
Arcadia Biosciences, Inc.'s 2028 outlook centres on $0.7883, within a $0.5894 to $1.13 range. That is -2% versus the projected 2027 average. That marks a +19% change versus current levels. A consolidation phase looks the most probable path here.
By 2029, RKDA could reach as high as $1.23, with a base case around $0.821 and support toward $0.5949 — roughly +24% from $0.6597. Momentum favours further upside here.
Expect RKDA to range from $0.5319 to $1.16 through 2030. The $0.7549 average target implies a +14% move from current prices. That is -8% versus the projected 2029 average. A consolidation phase looks the most probable path here.
The RKDA price prediction for 2031 points to an average of $0.7166 (low $0.4922, high $1.13) — a potential gain of +9% on today's $0.6597. Price action looks broadly range-bound.
In 2032, RKDA is projected to trade between $0.5057 and $1.22, averaging $0.7541 — a potential gain of +14% from today's $0.6597. That is up +5% on the projected 2031 average. A consolidation phase looks the most probable path here.
Arcadia Biosciences, Inc.'s 2033 outlook centres on $0.9194, within a $0.6028 to $1.52 range. That is up +22% on the projected 2032 average. That marks a +39% change versus current levels. Momentum favours further upside here.
By 2034, RKDA could reach as high as $1.76, with a base case around $1.05 and support toward $0.6732 — roughly +59% from $0.6597. Buyers look set to stay in control over this stretch.
Expect RKDA to range from $0.6305 to $1.72 through 2035. The $1.00 average target implies a +52% move from current prices. That is -4% versus the projected 2034 average. Momentum favours further upside here.
The RKDA price prediction for 2040 points to an average of $1.21 (low $0.6903, high $2.23) — a potential gain of +83% on today's $0.6597. Buyers look set to stay in control over this stretch.
In 2050, RKDA is projected to trade between $1.06 and $4.51, averaging $2.20 — a potential gain of +234% from today's $0.6597. That is up +82% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in RKDA today (≈ 1,515.840534 RKDA) could be worth
$3,338.07
+$2,338.07 (+234%) by 2050 · US Dollar
Based on the average projected RKDA price of $2.2 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in RKDAwould be worth at today's price.
$1,000 invested in RKDA on Jul 31, 2025 (≈ 232.558129 RKDA) would be worth
$153.42
-$846.58 (-84.7%) today · 0.15× · US Dollar
Based on a RKDA entry price of $4.3 vs. today's $0.6597.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.64 | $1,030.78 | +3.1% |
| 1 month ago | $0.749 | $880.77 | -11.9% |
| 3 months ago | $1.12 | $589.02 | -41.1% |
| 6 months ago | $2.01 | $328.21 | -67.2% |
| 1 year ago | $4.3 | $153.42 | -84.7% |
| All time (5.0y) ago | $96 | $6.87 | -99.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our RKDA forecast.
Our base-case forecast reaches $1.30 around 2050.
Implied market cap at $1.30: $2.84M
The multi-year forecast shows an upward trajectory in average prices and ROIs across the horizon. In 2026, the avg is $0.661 with a min of $0.62 and a max of $1.08, and the outlook is NEUTRAL with an ROI of 0. By 2027–2029, the averages rise (e.g., 2027 avg $0.8251, 2028 avg $0.8203, 2029 avg $0.8888) and bullish sentiment appears with ROIs of 24.8, 24.1, and 34.5 respectively.
The forecast continues to show positive momentum through the 2030s: 2030 avg $0.7285 with ROI 10.2 and NEUTRAL sentiment, then 2032 avg $0.7948 (ROI 20.3, BULLISH), 2033 avg $0.9375 (ROI 41.8, BULLISH), 2034 avg $1.11 (ROI 67.8, BULLISH), and 2035 avg $1.07 (ROI 62.5, BULLISH). The longer-horizon view strengthens further with 2040 avg $1.29 (ROI 94.8, BULLISH) and 2050 avg $2.32 (ROI 251.7, BULLISH). These are estimates, not guarantees, and reflect potential upside guided by the provided forecast.
Overall, the later-year figures illustrate meaningful upside potential from the 2026 base, though early years mix neutral signals with modest returns. Investors should be aware that forecasts are not guarantees and carry inherent uncertainty.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $0.7285 with a minimum of $0.4764 and a maximum of $1.20, and an ROI of 10.2, with a NEUTRAL sentiment.
The 2027–2029 period shows bullish sentiment with average prices around $0.8251 to $0.8888 and ROIs of 24.8, 24.1, and 34.5 respectively, while 2026 is NEUTRAL with an average of $0.661 and ROI of 0. These figures indicate potential upside in later years but are estimates, not guarantees, and should not be considered financial advice.
Yes. The forecast includes years with max values above $1, such as 2026 at $1.08, 2027 at $1.19, 2028 at $1.25, 2029 at $1.42, 2034 at $2.04, 2040 at $2.64, and 2050 at $5.35.
For 2040 the avg is $1.29 with a max of $2.64 and a min of $0.6196, and the sentiment is BULLISH with an ROI of 94.8.
Current price is $0.661 and market cap is $1.44M.
Arcadia Biosciences, Inc. Community Discussion
0Share your Arcadia Biosciences, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.